Cosopt/Cosopt-S

Cosopt/Cosopt-S Overdosage

dorzolamide + timolol

Manufacturer:

Santen

Distributor:

DKLL
Full Prescribing Info
Overdosage
No data are available with regard to human overdosage by accidental or deliberate ingestion of Cosopt/Cosopt-S.
There have been reports of inadvertent overdosage with timolol maleate ophthalmic solution resulting in systemic effects similar to those seen with systemic beta-adrenergic-blocking agents eg, dizziness, headache, shortness of breath, bradycardia, bronchospasm and cardiac arrest. The most common signs and symptoms to be expected with overdosage of dorzolamide are electrolyte imbalance, development of an acidotic state and possibly central nervous system effects.
Treatment should be symptomatic and supportive. Serum electrolyte levels (particularly potassium) and blood pH levels should be monitored. Studies have shown that timolol does not dialyze readily.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement